UTHR:NASDAQ
United Therapeutics Corp
554,73 $
arrow_downward
-0,78%(-4,37) 1D
554,73 $
0,00% (0,00)
bedtimeAfter hours
Closed: 20 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
561,20 $
High
563,12 $
Low
551,76 $
Mkt. cap
23,63 մլրդ
Avg. vol.
543,11 հզր
Volume
354,99 հզր
P/E ratio
20,93
52-wk high
614,23 $
52-wk low
455,63 $
EPS
26,51 $
Beta
0,49
Shares outstanding
42,59 մլն
No. of employees
1 հզր
Open
561,20 $
High
563,12 $
Low
551,76 $
Mkt. cap
23,63 մլրդ
Avg. vol.
543,11 հզր
Volume
354,99 հզր
P/E ratio
20,93
52-wk high
614,23 $
52-wk low
455,63 $
EPS
26,51 $
Beta
0,49
Shares outstanding
42,59 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Yahoo Finance
·
1 ժամ առաջ
United Therapeutics (UTHR) Stock May Be Below Fair Value Following EXTEND Trial Transplant News
Yahoo Finance
·
3 ժամ առաջ
United Therapeutics (UTHR) Stock Dropped, What Is Behind The Fresh Attention?
GuruFocus
·
8 ժամ առաջ
United Therapeutics (UTHR) Completes First Clinical Xenotranspla
Investing.com
·
12 ժամ առաջ
Chairperson & CEO Martine Rothblatt sells $3.13M United Therapeutics stock
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1,4 հզր
Founded1996
HeadquartersՍիլվեր Սփրինգ, Մերիլենդ, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websiteunither.com